secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bluejay Diagnostics, Inc. (BJDX)
CIK:        0001704287
Form:       8-K
Filed at:   2021-11-16T23:59:59+00:00
Accession:  0001213900-21-059650
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bluejay Diagnostics prices IPO of 2.16M units at $10/unit with warrants
-----------------------------------------------------------------------

- IPO of 2,160,000 units at $10 each closed Nov 15; each unit: share, Class A warrant ($7 exercise), Class B warrant ($10 exercise).
- Underwriters partially exercise option for additional 324,000 Class A and Class B warrants.
- $4.5M of 7.5% Senior Secured Convertible Debentures converted into Series D preferred, convertible into 4.5M common shares; resale registered.
- Gary Gemignani appointed to board as independent director, audit committee chair, and compensation committee member.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1704287/000121390021059650/0001213900-21-059650-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1704287/000121390021059650/ea150715-8k_bluejay.htm
  HTML page:      https://secwatch.observer/filing/0001213900-21-059650

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer